Several studies have shown that KO can attenuate inflammation in DSS-induced colitis by exerting anti-inflammatory effects to regulate the release of pro-inflammatory cytokines, including TNF-α, IL-1β, and IL-6, and elevate the expression of anti-inflammatory cytokine IL-10 [78,79], as shown in Table 1. This evidence concerns the gene IL1B and colitis.